Taxane-induced arthralgia and myalgia: A literature review.

Item

http://www.wikidata.org/entity/Q38711952

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Taxane-induced arthralgia and myalgia: A literature review.

@en

type

Item

label

Taxane-induced arthralgia and myalgia: A literature review.

@en

prefLabel

Taxane-induced arthralgia and myalgia: A literature review.

@en

P1476

Taxane-induced arthralgia and myalgia: A literature review.

@en

P2093

Edward Chow

http://www.w3.org/2001/XMLSchema#string

Henry Lam

http://www.w3.org/2001/XMLSchema#string

Leonard Chiu

http://www.w3.org/2001/XMLSchema#string

Mark Pasetka

http://www.w3.org/2001/XMLSchema#string

Nicholas Chiu

http://www.w3.org/2001/XMLSchema#string

Ronald Chow

http://www.w3.org/2001/XMLSchema#string

Sunil Verma

http://www.w3.org/2001/XMLSchema#string

P2860

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

Doxorubicin and paclitaxel in advanced breast carcinoma: importance of prior adjuvant anthracycline therapy.

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.

Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy.

Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.

A phase II study of single agent paclitaxel in patients at first relapse following initial chemotherapy for breast cancer.

Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study.

P304

56-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155215627502

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carlo Deangelis

P577

2016-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291952818

http://www.w3.org/2001/XMLSchema#string

P698

26811404

http://www.w3.org/2001/XMLSchema#string